Nielsen Jack
SEC-identified person · CIK 1602402 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Harmony Biosciences Holdings, Inc. HRMY | Director | filed 2020 - 2024 |
| Aligos Therapeutics, Inc. ALGS | Director | filed 2020 - 2024 |
| Instil Bio, Inc. TIL | Director | filed 2021 - 2024 |
| ALX Oncology Holdings INC ALXO | Director | filed 2020 - 2023 |
| IO Biotech, Inc. IOBT | Director | filed 2021 - 2023 |
| Reata Pharmaceuticals INC RETA | Director | filed 2016 - 2021 |
| Crinetics Pharmaceuticals, Inc. CRNX | Director | filed 2018 - 2019 |
| Lpath, INC LPTN.OB | Director | filed 2016 - 2016 |
| Akebia Therapeutics, Inc. AKBA | Director | filed 2014 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.